Drug studies in animals
Last updated: 2024 May 18
Total hit(s): 831
S.No.
1
38714327
Long-term stability and immunogenicity of lipid nanoparticle COVID-19 mRNA vaccine is affected by particle size.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
2
38692139
Collection and transportation of SARS-CoV-2 and influenza A virus diagnostic samples: Optimizing the usage of guanidine-based chaotropic salts for enhanced biosafety and viral genome preservation.
Biochem Biophys Res Commun
2024 Jun 30
2.73
1
3
38714446
Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development.
Vaccine
2024 May 6
3.31
1
4
38668705
Detection of Active SARS-CoV-2 3CL Protease in Infected Cells Using Activity-Based Probes with a 2,6-Dichlorobenzoyloxymethyl Ketone Reactive Warhead.
ACS Chem Biol
2024 May 17
8.5
1
5
38753462
The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development.
Emerg Microbes Infect
2024 May 16
5.84
1
6
38756610
The development and implementation of a low-cost mechanical ventilator in a low-middle-income country during the COVID-19 pandemic: The Unisabana-HERONS.
Heliyon
2024 May 15
1.65
1
7
38742905
Inhibition of endocytic uptake of severe acute respiratory syndrome coronavirus 2 and endo-lysosomal acidification by diphenoxylate.
Antimicrob Agents Chemother
2024 May 14
4.68
1
8
38745298
Effects of pulmonary rehabilitation on functional and psychological parameters in post-acute sequelae of SARS-CoV-2 infection (PASC) patients.
BMC Pulm Med
2024 May 14
2.21
1
9
38734638
Abrogation of ORF8-IRF3 binding interface with Carbon nanotube derivatives to rescue the host immune system against SARS-CoV-2 by using molecular screening and simulation approaches.
BMC Chem
2024 May 11
1
10
38749422
SARS-CoV-2 infection exacerbates the cellular pathology of Parkinson's disease in human dopaminergic neurons and a mouse model.
Cell Rep Med
2024 May 10
- n/a -
1
11
38643719
Molecular basis of N-glycan recognition by pradimicin a and its potential as a SARS-CoV-2 entry inhibitor.
Bioorg Med Chem
2024 May 1
6.5
1
12
38521646
Multidisciplinary Consensus on the Management of Non-Invasive Respiratory Support in the COVID-19 Patient.
Arch Bronconeumol
2024 May
0.98
1
13
38751871
Anti-cytokine Storm Activity of Fraxin, Quercetin, and their Combination on Lipopolysaccharide-Induced Cytokine Storm in Mice: Implications in COVID-19.
Iran J Med Sci
2024 May
3.4
1
14
38594459
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection.
Sci Rep
2024 Apr 9
4.12
1
15
38438233
Mass spectrometry study on SARS-CoV-2 recombinant vaccine with comprehensive separation techniques to characterize complex heterogeneity.
Anal Chim Acta
2024 Apr 8
5.31
1
16
38588829
Throat spray formulated with virucidal Pharmaceutical excipients as an effective early prophylactic or treatment strategy against pharyngitis post-exposure to SARS CoV-2.
Eur J Pharm Biopharm
2024 Apr 6
1
17
38575586
The metabolic footprint of Vero E6 cells highlights the key metabolic routes associated with SARS-CoV-2 infection and response to drug combinations.
Sci Rep
2024 Apr 4
4.12
1
18
38608595
In vitro pharmacokinetic behavior in lung of harringtonine, an antagonist of SARS-CoV-2 associated proteins: New insights of inhalation therapy for COVID-19.
Phytomedicine
2024 Apr 4
7.2
1
19
38677595
SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?
Antiviral Res
2024 Apr 25
4.12
1
20
38663935
Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination.
J Immunother Cancer
2024 Apr 24
8.66
1
21
38597182
Enteric coronavirus nsp2 is a virulence determinant that recruits NBR1 for autophagic targeting of TBK1 to diminish the innate immune response.
Autophagy
2024 Apr 16
10.79
1
22
38607273
The mouse to man conundrum: Revisiting an old lung injury model to study repurposed drugs for COVID-19 treatment.
Exp Physiol
2024 Apr 12
4.3
1
N/A
23
38607375
Genotoxicity and safety pharmacology of the rVSVInd(GML)-mspSGtc vaccine against SARS-CoV-2 in Sprague-Dawley rats and Beagle dogs.
Arch Toxicol
2024 Apr 12
5.66
1
24
38573021
Ursodeoxycholic acid may protect from severe acute respiratory syndrome coronavirus 2 Omicron variant by reducing angiotensin-converting enzyme 2.
Pharmacol Res Perspect
2024 Apr
3.3
1
25
38479071
Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron vaccine through enhanced humoral and cellular immunity.
Virology
2024 Mar 7
2.819
1